ArticleEye (London, England)2025
Risk factors associated with beta-peripapillary atrophy in individuals of African ancestry with primary open-angle glaucoma.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transformer Models, Graph Networks, and Generative AI in Gut Microbiome Research: A Narrative Review.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBeta-Peripapillary Atrophy (beta-PPA) is an optic nerve head change associated with primary open-angle glaucoma (POAG). We evaluated demographic, ocular, and genetic risk factors for beta-PPA in individuals of African ancestry with POAG.
methodsPOAG cases were recruited from the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study. Beta-PPA was defined as hypopigmentation with visible choroidal vessels and sclera adjacent to the optic disc. Univariable and multivariable regression models assessed risk factors for the presence and extent of beta-PPA.
resultsAmong 3381 eyes, 969 (28.6%) had beta-PPA. Beta-PPA was associated with older age (OR = 2.90, p < 0.001) and larger vertical cup-to-disc ratio (CDR) (OR = 1.58, p = 0.007), and was less common in females (OR = 0.53, p < 0.001). Beta-PPA presence was negatively associated with grey crescent (OR = 0.47, p = 0.01), neural rim notching (OR = 0.43, p = 0.01), and cylindrical (OR = 0.55, p < 0.001) or bean pot cup shapes (OR = 0.59, p < 0.001). Larger beta-PPA area was linked to older age (p = 0.008) and large vertical CDR (p = 0.03), but was less likely with conus pigmentosus (p = 0.001), deeper cup depth (p = 0.006), higher IOP (p = 0.005), and rounder discs (p = 0.01). Higher polygenic risk score (p = 0.007) and presence of the SNP rs34957764 in ROCK1P1 (p = 0.053) were associated with beta-PPA, but the same SNP was also associated with lesser area of beta-PPA (p = 0.03). Regions of beta-PPA correlated with greater RNFL loss (p < 0.01).
conclusionsBeta-PPA is strongly associated with older age and high CDR among individuals with POAG. These regions are vulnerable to RNFL loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.